Xuelei Ma

Title: Xuelei Ma: Innovator in Cancer Treatment

Introduction

Xuelei Ma is a notable inventor based in Sichuan, China. He has made significant contributions to the field of cancer treatment through his innovative research and patenting efforts. His work focuses on dietary interventions that may aid in cancer therapy.

Latest Patents

Xuelei Ma holds a patent titled "Dietary glycine and serine restriction for cancer treatment." This patent provides a food composition that includes a variety of amino acids or their salts. Specifically, it comprises about 0.0016-0.6 wt % of glycine or its salt and about 0.00109-1.2 wt % of serine or its salt. The patent also outlines a method for treating cancer by partially or completely substituting the normal diet of a subject with this food composition. Additionally, it suggests the option of administering a therapeutically effective amount of an anti-PD-1 antibody or an anti-PD-L1 antibody.

Career Highlights

Xuelei Ma is associated with Rplushealth Limited, where he continues to advance his research in dietary approaches to cancer treatment. His innovative ideas and dedication to improving patient outcomes have positioned him as a key figure in this area of study.

Collaborations

Xuelei Ma collaborates with talented individuals in his field, including Chengyuan He and Zhiwen Long. Their combined expertise contributes to the ongoing development of effective cancer treatment strategies.

Conclusion

Xuelei Ma's work exemplifies the intersection of nutrition and medical science, showcasing how dietary modifications can play a role in cancer treatment. His innovative patent and ongoing research efforts highlight the potential for new therapeutic approaches in oncology.